I’m excited today to share the news that the 2026 Asia Biological Summit will take place in Singapore on Tuesday 10 November 2026. The Summit will once again coincide with Singapore International Agrifood Week.

Last November, Wharf42, together with our Singapore-based partners, AgriFood Futures, co-hosted the inaugural Asia Biological Symposium. It attracted key stakeholders from across the ASEAN region. On 10 November this year, we intend to build on the foundations and networks created then, to deliver significant announcements around the framework being developed for the ASEAN Biological Platform.

So why is this Summit so important for Wharf42’s strategic partners in the US, New Zealand & Australia?

Collaborative cross-border partnerships will accelerate support for our farmers and growers

 

A foundation Wharf42 belief is that no single country or company can solve the complex challenges facing global food producers today. Nowhere is this more evident than in the global transition from chemical pesticides to biologicals.

In 2018, Wharf42 established Agritech New Zealand. In 2019, we co-founded the Australia New Zealand Agritech Council. In June, we’ll be convening the 4th Salinas Biological Summit. They all have one thing in common.

Building communities of growers, researchers, agritech companies, investors & policy-makers to accelerate impactful initiatives to support food producers. November’s Asia Biological Summit provides a valuable platform for our partners in the US, New Zealand & Australia to meet and engage with this most dynamic geographic region. Home to approximately 100 million smallholder farms, ASEAN’s agriculture sector contributes significantly to the region’s food production sector. So can you.

In her address last November, CDFA Secretary Ross highlighted the importance of cross-border collaboration; specifically, the opportunity for increased California/ASEAN regional collaboration. It was a message strongly supported by key New Zealand & Australian speakers on the day. Areas identified for increased collaboration included:
  • Accelerated cross-border research collaboration 
  • Increased investment into emerging biological companies
  • The opportunity to harmonize regulatory regimes across the region to accelerate the registration of new biological products  
In November, we’ll once again be bringing together key stakeholders from across the ASEAN region & beyond. We’ll be digging deeper into these highlighted areas and invite parties interested in engaging with these discussions to participate.